(Q50301134)

English

Brief report: two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autism.

scientific article published in February 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 March 2018

http://europepmc.org/abstract/MED/10097998

Brief report: two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autism. (English)

1 reference

Europe PubMed Central

2 March 2018

http://europepmc.org/abstract/MED/10097998

0 references

1 reference

based on heuristic

inferred from title

author name string

N A Dartnall

1

1 reference

Europe PubMed Central

2 March 2018

http://europepmc.org/abstract/MED/10097998

J P Holmes

2

1 reference

Europe PubMed Central

2 March 2018

http://europepmc.org/abstract/MED/10097998

S N Morgan

3

1 reference

Europe PubMed Central

2 March 2018

http://europepmc.org/abstract/MED/10097998

C J McDougle

4

1 reference

Europe PubMed Central

2 March 2018

http://europepmc.org/abstract/MED/10097998

language of work or name

0 references

publication date

1 February 1999

1 reference

Europe PubMed Central

2 March 2018

http://europepmc.org/abstract/MED/10097998

Journal of Autism and Developmental Disorders

1 reference

Europe PubMed Central

2 March 2018

http://europepmc.org/abstract/MED/10097998

29

1 reference

Europe PubMed Central

2 March 2018

http://europepmc.org/abstract/MED/10097998

1

1 reference

Europe PubMed Central

2 March 2018

http://europepmc.org/abstract/MED/10097998

87-91

1 reference

Europe PubMed Central

2 March 2018

http://europepmc.org/abstract/MED/10097998

https://scigraph.springernature.com/pub.10.1023/a:1025926817928

0 references

Risperidone as add-on therapy in behavioural disturbances in mental retardation: a double-blind placebo-controlled cross-over study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Case study: risperidone-induced hepatotoxicity in pediatric patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine Treatment of Children and Adults with Autistic Disorder and Mental Retardation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Case study: risperidone treatment of children and adolescents with developmental disorders.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A scatter plot for identifying stimulus control of problem behavior

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone in the treatment of pervasive developmental disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone and tardive dyskinesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Substituting traditional antipsychotics with risperidone for individuals with mental retardation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone and explosive aggressive autism

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1025926817928

1 reference

Europe PubMed Central

2 March 2018

http://europepmc.org/abstract/MED/10097998

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

2 March 2018

http://europepmc.org/abstract/MED/10097998

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50301134&oldid=1566646815"